BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25069980)

  • 1. Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar Typhimurium induces protection against a Trypanosoma cruzi lethal challenge.
    Matos MN; Cazorla SI; Bivona AE; Morales C; Guzmán CA; Malchiodi EL
    Infect Immun; 2014 Oct; 82(10):4265-75. PubMed ID: 25069980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.
    Matos MN; Cazorla SI; Schulze K; Ebensen T; Guzmán CA; Malchiodi EL
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005300. PubMed ID: 28234897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection.
    Matos MN; Sánchez Alberti A; Morales C; Cazorla SI; Malchiodi EL
    Vaccine; 2016 Jun; 34(28):3243-51. PubMed ID: 27177947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral multicomponent DNA vaccine delivered by attenuated Salmonella elicited immunoprotection against American trypanosomiasis.
    Cazorla SI; Matos MN; Cerny N; Ramirez C; Alberti AS; Bivona AE; Morales C; Guzmán CA; Malchiodi EL
    J Infect Dis; 2015 Mar; 211(5):698-707. PubMed ID: 25160983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
    Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
    Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.
    Ouaissi A; Guilvard E; Delneste Y; Caron G; Magistrelli G; Herbault N; Thieblemont N; Jeannin P
    J Immunol; 2002 Jun; 168(12):6366-74. PubMed ID: 12055254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
    Bhatia V; Garg NJ
    Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.
    Sepulveda P; Hontebeyrie M; Liegeard P; Mascilli A; Norris KA
    Infect Immun; 2000 Sep; 68(9):4986-91. PubMed ID: 10948115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.
    Eickhoff CS; Vasconcelos JR; Sullivan NL; Blazevic A; Bruna-Romero O; Rodrigues MM; Hoft DF
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e983. PubMed ID: 21408124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.
    Cazorla SI; Becker PD; Frank FM; Ebensen T; Sartori MJ; Corral RS; Malchiodi EL; Guzmán CA
    Infect Immun; 2008 Jan; 76(1):324-33. PubMed ID: 17967857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.
    Barbosa RP; Filho BG; Dos Santos LI; Junior PA; Marques PE; Pereira RV; Cara DC; Bruña-Romero O; Rodrigues MM; Gazzinelli RT; Machado AV
    PLoS One; 2013; 8(4):e61795. PubMed ID: 23637908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
    Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice.
    Lange UG; Mastroeni P; Blackwell JM; Stober CB
    Infect Immun; 2004 Aug; 72(8):4924-8. PubMed ID: 15271962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
    Miller MJ; Wrightsman RA; Manning JE
    Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.